- Home
- ALAR vs MGTX Comparison
ALAR vs MGTX Comparison
Compare ALAR & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALAR
- MGTX
- Stock Information
- Founded
- ALAR 2013
- MGTX 2015
- Country
- ALAR Israel
- MGTX United States
- Employees
- ALAR N/A
- MGTX N/A
- Industry
- ALAR Computer Software: Prepackaged Software
- MGTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ALAR Technology
- MGTX Health Care
- Exchange
- ALAR Nasdaq
- MGTX Nasdaq
- Market Cap
- ALAR 70.7M
- MGTX 411.4M
- IPO Year
- ALAR 2018
- MGTX N/A
- Fundamental
- Price
- ALAR $18.51
- MGTX $5.99
- Analyst Decision
- ALAR Strong Buy
- MGTX Strong Buy
- Analyst Count
- ALAR 2
- MGTX 2
- Target Price
- ALAR $25.50
- MGTX $22.50
- AVG Volume (30 Days)
- ALAR 403.8K
- MGTX 322.0K
- Earning Date
- ALAR 11-26-2024
- MGTX 11-12-2024
- Dividend Yield
- ALAR N/A
- MGTX N/A
- EPS Growth
- ALAR N/A
- MGTX N/A
- EPS
- ALAR 0.07
- MGTX N/A
- Revenue
- ALAR $31,117,000.00
- MGTX $8,122,000.00
- Revenue This Year
- ALAR $22.15
- MGTX $133.83
- Revenue Next Year
- ALAR $11.59
- MGTX $655.34
- P/E Ratio
- ALAR $29.65
- MGTX N/A
- Revenue Growth
- ALAR 52.26
- MGTX 26.87
- 52 Week Low
- ALAR $2.92
- MGTX $3.49
- 52 Week High
- ALAR $46.69
- MGTX $7.60
- Technical
- Relative Strength Index (RSI)
- ALAR 70.83
- MGTX 78.52
- Support Level
- ALAR $8.97
- MGTX $3.97
- Resistance Level
- ALAR $21.50
- MGTX $6.07
- Average True Range (ATR)
- ALAR 1.53
- MGTX 0.33
- MACD
- ALAR 1.28
- MGTX 0.22
- Stochastic Oscillator
- ALAR 76.14
- MGTX 89.00
About ALAR Alarum Technologies Ltd.
Alarum Technologies Ltd is a company engaged in the information security business. The company has two Internet access segments which include Enterprise Internet Access and Consumer Internet Access. Its Enterprise Internet Access offers web data collection and a private Internet browsing platform and Consumer Internet Access provides solutions for secure and private Internet browsing. Geographically, the company has a presence in the UK Virgin Islands, Israel, Europe, APAC, MEA, Hong Kong, the USA, and others, and generates a majority of its revenue from the APAC followed by the United States.
About MGTX MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.